Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
636
datasets available to search
ShareScore release 0.9.0
Dataset results
636 results for “Chimerism”
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL
ClinicalTrials.gov study NCT03919526. IPD Sharing: NO. Countries: 1. Publications: 0.
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06757881. IPD Sharing: NO. Countries: 1. Publications: 0.
Do Alemtuzumab Levels Predict T Cell Chimerism After MSD SCT for SCD?
ClinicalTrials.gov study NCT05905770. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
ClinicalTrials.gov study NCT06462248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
ClinicalTrials.gov study NCT05773040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
ClinicalTrials.gov study NCT05554575. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
ClinicalTrials.gov study NCT03980288. IPD Sharing: NO. Countries: 1. Publications: 0.
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
ClinicalTrials.gov study NCT06701201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT05243212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic M
ClinicalTrials.gov study NCT06191887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04394650. IPD Sharing: YES. Countries: 1. Publications: 0.
Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04067414. IPD Sharing: NO. Countries: 1. Publications: 0.
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
ClinicalTrials.gov study NCT05038696. IPD Sharing: NO. Countries: 1. Publications: 0.
Delayed Tolerance Through Mixed Chimerism
ClinicalTrials.gov study NCT05900401. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
ClinicalTrials.gov study NCT06559189. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07240857. IPD Sharing: Not stated. Countries: 0. Publications: 0.
CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06777979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
ClinicalTrials.gov study NCT05797233. IPD Sharing: YES. Countries: 1. Publications: 0.
CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies
ClinicalTrials.gov study NCT06316856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT06585514. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.